NEW

COVID-19 PBMCs

Peripheral blood mononuclear cells (PBMCs) from acute & recovered COVID-19 patients. Characterized cell populations.

$500.00  
CoV-PBMC-10
* Samples will be made available for purchase before the PBMCs are characterized. Lead time for cell characterization is 2 weeks. For a list of available samples, cell profile, and patient information, contact [email protected]
+

Product Specifications

Size:
10 or 100 million PBMCs
Species:
Human
Sample Type:
Peripheral blood mononuclear cells (PBMCs)
Characterized Markers:
Major histocompatibility complex: HLA I & HLA II typed
B-cells: CD20
Monocytes: CD14, CD16
NK cells: CD56
T cells: CD3, CD4, CD8, CCR7, CD45RA, CD127
Cell viability is also provided.
Anticoagulant:
EDTA
Format:
Frozen with 10% DMSO
Shipping temperature:
Shipped on dry ice
Biosafety Level:
2
Note: While the patients were confirmed to have COVID-19 via a test detecting either SARS-CoV-2 virus or viral proteins using a nasopharyngeal swab, the PBMC samples have not been tested for the presence of virus or any other diseases and should be assumed infectious.

No posts found

Write A Review

Usage

This product is furnished for LABORATORY RESEARCH USE ONLY.
Not for diagnostic or therapeutic use.